Work

A phase I/II study combining dasatinib (D) and erlotinib (E) in non-small cell lung cancer.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.8102

Authors: Faye M. Johnson, XiMing Tang, Hai T. Tran, Chelsey Mc Intyre, Justina Price, J. Jack Lee, Nusrat Harun, Ignacio Ivan Wistuba, Kathryn A. Gold

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601003767

Cites:

Cited by: 4

Related to: 10